Guest column: rebuttal to gatekeepers to pharmaceuticals.
Feldman
Jane H
JH
Northwestern University, Chicago, Illinois, USA.
D002986:Clinical Trials as Topic; D000075202:Contraindications; D003657:Decision Making / Q000502:physiology; D004334:Drug Administration Schedule; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D004366:Nonprescription Drugs / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D011600:Psychopharmacology / Q000639:trends; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use; D012017:Referral and Consultation / Q000639:trends*; D012651:Self Medication / Q000009:adverse effects / Q000639:trends; D013997:Time Factors
D004366:Nonprescription Drugs; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs